On Friday, Adaptive Biotechnologies Corp (NASDAQ: ADPT) was -15.52% drop from the session before settling in for the closing price of $17.46. A 52-week range for ADPT has been $5.80 – $20.76.
A company in the Healthcare sector has dropped its sales by -1.51% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 54.78%. With a float of $146.70 million, this company’s outstanding shares have now reached $152.58 million.
Adaptive Biotechnologies Corp (ADPT) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Adaptive Biotechnologies Corp stocks. The insider ownership of Adaptive Biotechnologies Corp is 4.05%, while institutional ownership is 93.91%. The most recent insider transaction that took place on Dec 03 ’25, was worth 506,415. In this transaction Chief Scientific Officer of this company sold 27,212 shares at a rate of $18.61, taking the stock ownership to the 1,242,312 shares. Before that another transaction happened on Dec 04 ’25, when Company’s Chief Scientific Officer sold 10,000 for $16.61, making the entire transaction worth $166,100. This insider now owns 1,232,312 shares in total.
Adaptive Biotechnologies Corp (ADPT) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.23 earnings per share (EPS) during the time that was better than consensus figure (set at -0.24) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.59% during the next five years compared to -1.51% drop over the previous five years of trading.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators
You can see what Adaptive Biotechnologies Corp (ADPT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.54, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Adaptive Biotechnologies Corp (ADPT)
Let’s dig in a bit further. During the last 5-days, its volume was 3.55 million. That was better than the volume of 2.06 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 19.86%.
During the past 100 days, Adaptive Biotechnologies Corp’s (ADPT) raw stochastic average was set at 44.38%, which indicates a significant increase from 19.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.32 in the past 14 days, which was higher than the 0.81 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.23, while its 200-day Moving Average is $11.63. However, in the short run, Adaptive Biotechnologies Corp’s stock first resistance to watch stands at $15.78. Second resistance stands at $16.82. The third major resistance level sits at $17.38. If the price goes on to break the first support level at $14.18, it is likely to go to the next support level at $13.62. The third support level lies at $12.58 if the price breaches the second support level.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Key Stats
There are 152,665K outstanding shares of the company, which has a market capitalization of 2.25 billion. As of now, sales total 178,960 K while income totals -159,490 K. Its latest quarter income was 93,970 K while its last quarter net income were 9,550 K.
